Transaction DateRecipientSharesTypePriceValue
Cardax logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.

Cardax, Inc. focuses on astaxanthin, which is a powerful and safe naturally occurring anti-inflammatory without the side effects of currently marketed anti-inflammatories. The firm's product platform consists of a commercially available dietary supplement, ZanthoSyn.

Ticker: CDXI
Sector: Health Technology
Industry: Pharmaceuticals: Other
SEC Central Index Key (CIK): 1544238
Employees: 11
Exchange: US OTC
Auditor Opinion:

Disclosure Language changes
Red Flags